General Report

Clinical imaging and pathological analysis of fibro-adipose vascular anomaly in children

  • Xueli WANG ,
  • Lian CHEN ,
  • Qingyu WANG ,
  • Bin ZHANG
Expand
  • 1. Department of Pathology, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
    2. Department of Pathology, Children's Hospital of Fudan University, Shanghai 201102, China

Received date: 2022-06-22

  Online published: 2022-12-06

Abstract

Objective To summarize the clinicopathological features of fibro-adipose vascular anomaly (FAVA) in children, explore its diagnosis and treatment, improve the understanding of the disease by clinicians and pathologists, and reduce the rate of misdiagnosis. Methods The clinical data of 22 children with suspected FAVA admitted from July 2016 to February 2022 were retrospectively analyzed. According to the clinical data, the clinical characteristics were analyzed, and the key points of imaging and pathological diagnosis were summarized. Results Twenty-two patients (11 boys and 11 girls, with mean age of 7.22 years) met the clinical, radiological, and histopathological inclusion criteria for FAVA. The clinical presentation is a slow-growing mass with pain and/or contracture. Magnetic resonance imaging showed heterogeneous intramuscular, intermuscular or subcutaneous high and low signal mixed diffuse lesions with venous dilatation. Pathological findings included dense fibrous tissue in skeletal muscle, excessive fat, focal aggregation of blood vessels, lymphatics and lymphocytes and plasma cells, vascular hyperplasia, and skeletal muscle atrophy. In 22 cases, except for 2 cases of palliative resection and 1 case of local disengagement surgery, the remaining 19 cases underwent macroscopic complete resection. The follow-up period ranged from 2 months to 5 years and 10 months. Two children recurred, with a recurrence rate of 10.5%. The pain disappeared in all children except the recurrence cases.Conclusions Early surgery is recommended for vascular tumors/malformations that do not respond to repeated sclerotherapy and for those that cannot be clearly diagnosed clinically or radiographically. Postoperative pathology can confirm the diagnosis, and surgery can achieve the purpose of treatment.

Cite this article

Xueli WANG , Lian CHEN , Qingyu WANG , Bin ZHANG . Clinical imaging and pathological analysis of fibro-adipose vascular anomaly in children[J]. Journal of Clinical Pediatrics, 2022 , 40(12) : 939 -943 . DOI: 10.12372/jcp.2022.22e0863

References

[1] Alomari AI, Spencer SA, Arnold RW, et al. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity[J]. J Pediatr Orthop, 2014, 34(1): 109-117.
[2] Amarneh M, Shaikh R. Clinical and imaging features in fibro-adipose vascular anomaly (FAVA)[J]. Pediatr Radiol, 2020, 50(3): 380-387.
[3] Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics[J]. Plast Reconstr Surg, 1982, 69(3): 412-422.
[4] Wassef M, Borsik M, Cerceau P, et al. Classification of vascular tumours and vascular malformations. Contribution of the ISSVA 2014/2018 classification[J]. Ann Pathol, 2021, 41(1): 58-70.
[5] Hori Y, Hirose K, Aramaki-Hattori N, et al. Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway[J]. Diagn Pathol, 2020, 15(1): 98.
[6] Hori Y, Hirose K, Ozeki M, et al. Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA)[J]. Diagn Pathol, 2022, 17(1): 43.
[7] Lipede C, Nikkhah D, Ashton R, et al. Management of fibro-adipose vascular anomalies (FAVA) in paediatric practice[J]. JPRAS Open, 2021, 29: 71-81.
[8] Shaikh R, Alomari AI, Kerr CL, et al. Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option[J]. Pediatr Radiol, 2016, 46(8): 1179-1186.
[9] Erickson J, McAuliffe W, Blennerhassett L, et al. Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients[J]. Pediatr Dermatol, 2017, 34(6): e317-e320.
[10] 刘大看, 龚毓宾, 左松, 等. 34例下肢法瓦病临床分析[J]. 中华整形外科杂志, 2017, 33(6): 433-437.
[11] 谢崇, 王怀杰, 蔺卫龙, 等. 法瓦病诊疗方法的初步探索[J]. 中华小儿外科杂志, 2022, 43(2): 146-150.
[12] 胡文笳, 刘昱晗, 董长宪, 等. 下肢法瓦病与静脉畸形的超声影像学特征解析[J]. 中华整形外科杂志, 2022, 38(3): 259-264.
Outlines

/